Pri-Med Jacksonville

Jacksonville, FL | November 15-16, 2018

Prime F. Osborn III Convention Center

Updates from the 2018 ACC Scientific Sessions: Important Takeaways That Will Change Clinical Practice


This session will review a number of clinically relevant trials/topics recently presented at the American College of Cardiology Scientific Sessions in March 2018, including updates in the management of patients with hypercholesterolemia, heart failure, valvular heart disease, arrhythmias, and more.

Learning Objectives

Interpret outcomes data for PCSK9 inhibitors and determine how these studies will impact management of hypercholesterolemia in at-risk individuals

Recognize that transcatheter aortic valve replacement (TAVR) has become a standard procedure for patients with aortic stenosis at intermediate and high surgical risk

Understand that direct oral anticoagulants will be used more frequently to reduce thrombotic risk in patients with an acute coronary syndrome, atrial fibrillation, and/or a venous thromboembolism

Distinguish among diabetes medications in their ability to reduce the risk of heart failure readmission

Integrate guidance for periprocedural management of anticoagulation into clinical practice


Download PDF of Presented Slides



Ty J. Gluckman, MD, FACC, FAHA

Ty J. Gluckman, MD, FACC, FAHA, is medical director of the Center for Cardiovascular Analytics, Research, and Data Science (CARDS) at the Providence St. Joseph Heart Institute in Portland, Oregon and an adjunct faculty member of the Ciccarone Center ...

View Full Bio